Follow the JCRファーマ株式会社 share price and the full management transaction log of the company, a listed issuer based in Japan. Shares trade on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, JCRファーマ株式会社 has recorded 11 reports. Market capitalisation: €169.7bn. The latest transaction was disclosed on 20 February 2025 (Holding update). Among the most active insiders: Nomura Asset Management Co., Ltd.. All data is accessible without an account.
Analysts rate JCRファーマ株式会社 Buy (bullish), based on 6 analysts. Average price target: JP¥4,833.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
11 of 11 declarations
JCR Pharma, Inc. es una empresa especializada en el sector sanitario y farmacéutico. Cotiza en el mercado XTKS.